Scholarlink

<p>The preparation of a dual immunosensor for the simultaneous determination of two important microbiome-related oral disease biomarker matrix metalloproteinases MMP-9 and MMP-13 is reported. Screen-printed dual carbon electrodes (SPdCEs) modified with reduced graphene oxide and crystalline nanocellulose (rGO/CNC) were used for the immobilization of specific capture antibodies and the implementation of sandwich-type immunoassays using biotinylated secondary antibodies. Amperometric detection through the hydroquinone HQ/H<sub>2</sub>O<sub>2</sub> system was employed. The limits of detection (<i>LOD</i>) achieved were 0.25 and 0.30&#xa0;ng&#xa0;mL<sup>−1</sup> for&#xa0;MMP-9 and MMP-13, respectively. The developed immunosensor proved to be useful for the determination of both MMPs in saliva from healthy individuals and patients of periodontitis as well as in serum from patients diagnosed with rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD). The obtained results agreed with those provided by commercial ELISA kits, and the developed dual immunosensor proved to be competitive versus this methodology, requiring less than 2&#xa0;h for the simultaneous determination of both biomarkers.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Nanocellulose-modified electrodes for simultaneous biosensing of microbiome-related oral diseases biomarkers

  • 期刊论文

  • 发表日期：

    2025年2月11日

查看全文
  • C. Ramos-López,
  • L. García-Rodrigo,
  • E. Sánchez-Tirado,
  • A. González-Cortés,
  • L. Agüí,
  • P. Yáñez-Sedeño,
  • J. M. Pingarrón

摘要

The preparation of a dual immunosensor for the simultaneous determination of two important microbiome-related oral disease biomarker matrix metalloproteinases MMP-9 and MMP-13 is reported. Screen-printed dual carbon electrodes (SPdCEs) modified with reduced graphene oxide and crystalline nanocellulose (rGO/CNC) were used for the immobilization of specific capture antibodies and the implementation of sandwich-type immunoassays using biotinylated secondary antibodies. Amperometric detection through the hydroquinone HQ/H2O2 system was employed. The limits of detection (LOD) achieved were 0.25 and 0.30 ng mL−1 for MMP-9 and MMP-13, respectively. The developed immunosensor proved to be useful for the determination of both MMPs in saliva from healthy individuals and patients of periodontitis as well as in serum from patients diagnosed with rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD). The obtained results agreed with those provided by commercial ELISA kits, and the developed dual immunosensor proved to be competitive versus this methodology, requiring less than 2 h for the simultaneous determination of both biomarkers.

Graphical Abstract